試す 金 - 無料
We Aim To Have Over 2.5 Lakh Chemist Shops Computerised
Express Pharma
|October 16-31, 2019
Technology intervention in the Indian pharma supply chain would enable reduction of mismanagement in inventory and weed out counterfeits from the system, informs Sudhir Singh, Managing Director, Marg ERP to Akanki Sharma
Why is supply chain management a challenge for the Indian pharma industry? Where does India stand in terms of supply chain when compared to other countries?
Compared to developed countries, supply chain of pharma industry in India is fragmented, and suffers loosely managed inventory threats. A country of our size requires a lot of inclusive pharma distribution which is largely being done via supply chain. We need a large and efficient tech-enabled supply chain to serve the country’s need. Currently, the country has approximately more than two lakh distributors including wholesalers, traders and C&F agents, and approximately over nine lakh retail points. If we talk about the distributors, they are appropriate in number but the retail side of the trade penetrates deeper. It increases every year by 20 percent.
Some experts argue that Indian pharma industry is over-regulated, but being regulated adds up to the products' structured distribution, which, compared to many countries, is far ahead in reach, depth and quality. Nevertheless, there are gaps which need to be bridged before we can actually call the supply chain all-inclusive and secure. We do have possibilities of digitalisation (the digitalisation in the supply chain management through distributors to retailers to customers) that will make it more robust and effective. Currently, there are 70 percent of pharmacists who still need to digitise their business. Technology intervention in the Indian pharma supply chain would enable reduction of mismanagement in inventory and weed out counterfeits from the system.
What software do you have for catering to the Indian pharma industry? How many pharma companies do you offer your solutions to? Kindly name some of these.
このストーリーは、Express Pharma の October 16-31, 2019 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Express Pharma からのその他のストーリー
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
